Published in Int J Health Care Qual Assur on October 12, 2015
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer (2008) 4.41
Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer (2011) 2.95
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst (2014) 2.26
Health-related Internet use by patients with somatic diseases: frequency of use and characteristics of users. Inform Health Soc Care (2009) 1.76
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer (2006) 1.55
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol (2012) 1.51
[Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients]. Ned Tijdschr Geneeskd (2016) 1.38
Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer (2012) 1.23
Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989. Eur J Cancer (2010) 1.21
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer (2008) 1.13
Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001. Eur J Obstet Gynecol Reprod Biol (2008) 1.05
Educational needs of general practitioners in palliative care: outcome of a focus group study. J Cancer Educ (2005) 0.98
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer (2012) 0.96
Detection of cancer before distant metastasis. BMC Cancer (2013) 0.94
Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989-2003. Eur J Cancer Prev (2008) 0.90
Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer (2011) 0.89
Easy navigating through the forest of survivorship care. J Clin Oncol (2013) 0.89
Age-specific differences in the treatment of cervical cancer in the east and the south of The Netherlands 1989-2004. Eur J Obstet Gynecol Reprod Biol (2009) 0.85
Disparities in survival of stomach cancer among different socioeconomic groups in North-East Netherlands. Cancer Epidemiol (2011) 0.84
Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up. Mov Disord (2004) 0.84
Assessment of cancer risks due to environmental exposure to asbestos. J Expo Sci Environ Epidemiol (2009) 0.84
Early-stage young breast cancer patients: impact of local treatment on survival. Int J Radiat Oncol Biol Phys (2011) 0.83
The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor. Gynecol Oncol (2010) 0.82
Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women. BMC Cancer (2014) 0.82
Quantifying culture gaps between physicians and managers in Dutch hospitals: a survey. BMC Health Serv Res (2010) 0.82
Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003. Int J Gynecol Cancer (2010) 0.82
Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP-3 survey. Int J Cancer (2012) 0.82
Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only. Obstet Gynecol Int (2011) 0.81
A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast (2013) 0.81
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences. Breast Cancer Res Treat (2012) 0.80
Diverging breast and stomach cancer incidence and survival in migrants in The Netherlands, 1996-2009. Acta Oncol (2012) 0.80
Does lowering the screening age for cervical cancer in The Netherlands make sense? Int J Cancer (2008) 0.80
Attending the breast screening programme after breast cancer treatment: a population-based study. Cancer Epidemiol (2013) 0.79
[Resection of liver metastases in breast cancer]. Ned Tijdschr Geneeskd (2015) 0.78
Pattern of follow-up care and early relapse detection in breast cancer patients. Breast Cancer Res Treat (2012) 0.78
[Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator]. Ned Tijdschr Geneeskd (2010) 0.77
Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients. Breast Cancer Res Treat (2015) 0.77
Retracted Breast and stomach cancer incidence and survival in migrants in the Netherlands, 1996-2006. Eur J Cancer Prev (2011) 0.77
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. Cancer Epidemiol (2013) 0.76
Immediate Breast Reconstruction in The Netherlands and the United States: A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data. Plast Reconstr Surg (2019) 0.75
Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers? Eur J Cancer Prev (2013) 0.75
Factors Associated with the Use of Gene Expression Profiles in Estrogen Receptor-Positive Early-Stage Breast Cancer Patients: A Nationwide Study. Public Health Genomics (2016) 0.75
[The value of ipsilateral breast tumor recurrence as a quality indicator: hospital variation in the Netherlands]. Ned Tijdschr Geneeskd (2015) 0.75
Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. Anticancer Drugs (2016) 0.75
Long-term effects of a regional care pathway for patients with rectal cancer. Int J Colorectal Dis (2015) 0.75